Overview

Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer

Status:
Terminated

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

Rationale: Computer systems that allow doctors to create a 3 dimensional (3-D) picture of the tumor may help in planning radiation therapy and may result in more tumor cells being killed. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs, such as cisplatin, may make tumor cells more sensitive to radiation therapy.

Phase:

N/A

Details

Lead Sponsor:

Abramson Cancer Center of the University of Pennsylvania

Treatments:

Cisplatin